Fifteen Years of Surgery for Rare Tumors Deep Inside the Brain
Original title: Clinical Outcomes and Prognostic Factors Following Surgery for Supratentorial Intraventricular Tumours: A 15-year Experience.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at surgeries already done, not a test of anything new.
The short version
Most people did well after surgery for these rare deep brain tumors, but the risks were real.
What was studied. Doctors looked back at the records of 170 patients. All had surgery for rare tumors in the fluid spaces deep inside the brain. The surgeries were done between 2010 and 2025.
What they found. The whole tumor was removed in 87 of 147 patients. Problems after surgery happened in 52 of 145 patients. These included meningitis in 9 people and fluid buildup in the brain in 9 people. The tumor came back in 22.7% of people. 4.2% died within thirty days. Children and people with high grade tumors did worse.
What this means, and what it doesn't
What it could mean: Surgery can lead to a good result for most people with these rare tumors. Tumors that grow slowly were easier to remove in full. If fluid is already building up in your brain, your team may plan a drain ahead of time. Numbers like these can help your surgeon talk with you about what to expect.
What it doesn't mean: This is not a cure and not a promise about your own case. It was a look back at past records at one hospital. No new treatment or new device was tested here. A study like this cannot prove what caused each result. Your own risk depends on your tumor, your age, and your health. Talk with your own care team.
Source: PubMed, September 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.